Softgel Source, LLC (SGS) announced its 2026 program for rapid turnaround of low volume, custom ingestible softgels, offering production priority and no minimum order quantity (MOQ) to facilitate quick product testing. The program, based in Portland, Oregon, aims to support U.S. companies in bringing manufacturing back home amid challenges such as disrupted international supply chains, long lead times, and shifting tariffs.
“U.S. companies are at a crossroads, facing both the challenge and opportunity of bringing manufacturing back home,” said Kevin McDowell, Founder and CEO of Softgel Source, LLC. “By having our headquarters in Portland, Oregon USA, we're well-positioned to help U.S. biotech and pharmaceutical businesses rapidly develop and test new and improved softgel products and formulations, creating a stronger competitive edge in their product marketplace.”
The expansion aligns with a nationwide surge in U.S. manufacturing. According to a study from Deloitte and The Manufacturing Institute, U.S. manufacturing job growth is expected to continue this decade, requiring millions of new workers. Biotech and pharmaceutical manufacturing, in particular, are projected to grow 6–8% annually through 2030.
Businesses dependent on offshore manufacturing are increasingly feeling the strain of disrupted international supply chains, long lead times, poor customer service and shifting tariffs. But with these challenges comes opportunities. Manufacturers that invest now in rapidly developing and testing their new products domestically will be best positioned to diversify, expand, and thrive in this new era of U.S. manufacturing.
“Located in the Pacific Northwest, SGS is ideally positioned to help companies address these offshore manufacturing issues,” continued McDowell. “We help companies rapidly test, scale and adapt by offering U.S.-manufactured softgels that meet the highest standards of quality and compliance at fast turnaround rates. From biotech labs to innovative nutritional supplements, the company delivers solutions that enable efficiency, consistency, and growth. We're also an excellent choice for backup production when offshore sources falter.”
Additionally, constant major changes in regulations can have potentially disruptive implications for U.S. softgel suppliers in diverse markets. Many products will routinely need to be reformulated and retested to comply with the changes, often on short notice.
“Continuous changes in U.S. and international regulations mean that many companies with softgel products affected by those changes need a way to rapidly test new products and formulations and get updated products into production fast,” added McDowell. “A local U.S. based manufacturer like SGS with fast turnaround and low MOQ is ideal for companies dealing with those types of time sensitive reformulation and testing requirements.”
Softgel Source (SGS) is a boutique manufacturer of custom ingestible softgels for the vitamin, medication, supplement and pet product industries. Located in Portland, Oregon, SGS focuses on high touch custom softgel manufacturing for U.S. based clients focused on responsive, rapid turnaround of prototype production and low-to-moderate volume softgel manufacturing. More information is available at https://softgelsource.com.
